HIV 相关脂肪营养不良的研究进展
摘要
关键词
全文:
PDF参考
Foka TEF, Mufhandu TH. Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review[J]. Viruses, 2023, 15(8):1732
Lamesa AT. Biological Depiction of Lipodystrophy and Its Associated Challenges Among HIV AIDS Patients: Literature Review[J]. HIV/AIDS (Auckland, N.Z.), 2024, 16: 123-132.
Agnieszka L, Andrzej Z, Michał P, et al. Human Immunodeficiency Virus as a Risk Factor for Cardiovascular Disease[J]. Cardiovascular toxicology, 2023, 24(1): 1-14.
蔡琼,孙燕,潘薇,等.艾滋病与冠心病关联性的研究趋势及可视化分析[J].医学动物防制,2025,41(03):246-253.
Bailin SS, Gabriel LC, Gangula DR, et al. Single-cell Analysis of Subcutaneous Fat Reveals Pro-fibrotic Cells that Correlate with Visceral Adiposity in HIV[J]. The Journal of clinical endocrinology and metabolism, 2024, 110(1): 238-253.
H R L, David C, Christopher K, et al. Obesity I: Overview and molecular and biochemical mechanisms[J]. Biochemical pharmacology, 2022, 199, 115012-115012.
A G M, S E D, MaryAnn O, et al. Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202[J]. The Journal of infectious diseases, 2013, 207(4): 604-611.
申晓涵,徐芙蓉,徐立然,等.中西医结合治疗艾滋病高脂血症：全身调节与靶向干预并行[J].中国艾滋病性病,2025,31(05):558-561.
魏利君,李惠琴.AIDS患者心血管疾病发病危险因素及风险评估方法研究进展[J].山东医药,2023,63(12):106-111.
夏玉朝,杨萱,张雪,等.艾滋病抗病毒治疗引起脂肪营养不良综合征回顾性分析[J].中国艾滋病性病,2019,25(02):169-171+181.
于桢钰,张淼,马素娜,等.人类免疫缺陷病毒相关脂肪营养不良综合征与过氧化物酶体增殖物激活受体γ关系及中医药治疗现状[J].河北中医,2021,43(07):1228-1232.
C J G, Shubhnita S, C M W A, et al. Adipokines: Deciphering the Cardiovascular Signature of Adipose Tissue[J]. Biochemical pharmacology, 2022, 206, 115324-115324.
J L C, J T B, W A R, et al. Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy[J]. AIDS (London, England), 2015, 29(16): 2201-2207.
Hinton O A, N’jai U A, Vue Z, et al. Connection Between HIV and Mitochondria in Cardiovascular Disease and Implications for Treatments[J]. Circulation research, 2024, 134(11): 1581-1606.
J L C, J T B, W A R, et al. Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy[J]. AIDS (London, England), 2015, 29(16): 2201-2207.
Key D D P, Jadi K P, Gill B N, et al. A Closer Look into White Adipose Tissue Biology and the Molecular Regulation of Stem Cell Commitment and Differentiation[J]. Genes, 2024, 15(8): 1017-1017.
Enrico R, Lea B, Marek K, et al. Reduction of CD8 T cell functionality but not inhibitory capacity by integrase inhibitors[J]. Journal of virology, 2022, 96(5): JVI0173021-JVI0173021.
Chinonso E O, Anushka N, E K D, et al. Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection[J]. Expert review of clinical pharmacology, 2023, 16(10): 939-957.
L T S, Julian F, Christian M, et al. Reduction in visceral adiposity is associated with an improved2 metabolic profile in HIV-infected patients receiving tesamorelin[J]. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, 54(11): 1642-1651.
赵昱,王保金.运动对HIV感染者的综合健康效益研究进展[J].中国艾滋病性病,2021,27(07):789-793.
齐唐凯,卢洪洲.艾滋病相关代谢综合征及其治疗[J].世界临床药物,2012,33(03):137-139.
T L F , K S G. Approach to the Patient with Lipodystrophy [J]. The Journal of clinical endocrinology and metabolism, 2022,107(6): 1714-1726.
Temitayo O O , Busayo S O, Rebecca T O, et al. Effect of intake of probiotics and probiotic fermented foods on clinical outcomes among people living with HIV: A systematic review and meta-analysis[J]. Tropical medicine & international health : TM & IH, 2023, 29(2): 113-127.
DOI: http://dx.doi.org/10.12345/nrr.v4i3.31591
Refbacks
- 当前没有refback。
